Cytokinetics Inc (CYTK)

EBITDA Margin

-611.43%

Quarterly · Period ending:

CYTK logo

CYTK EBITDA Margin

Latest reported-611.43%
CYTK Quarterly EBITDA Margin (-182.14% → -611.43%)
High-resolution chart · PNG

CYTK ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-611.4276%
-874.8024%
-1,014.7564%
-14,316.9938%
-161.4821%
-8,621.2793%
-738.7192%
-29,338.2289%
-46,832.5301%
-13,891.1377%
-6,788.0981%
-30,045.5026%
-13,081.3149%
-2,498.6993%
-6,103.8835%
-4,948.5089%
-9.6698%
-6,863.5889%
-38.3939%
-1,260.0331%
-1,901.7587%
-607.5748%
-502.6778%
13.721%
-850.5427%
-783.1111%
-421.815%
-372.7663%
-355.7797%
-272.8143%
-219.2492%
-153.3972%
-348.6565%
-467.2741%
195,350%
-440.0485%
-790.7959%
-539.2247%
10.2963%
57.8217%
-186.8494%
-139.9359%
-90.9091%
-110.0315%
-159.6148%
-198.5501%
39.3327%
-62.3686%
-106.3816%
-108.5976%
26.7773%
-279.9284%
-1,481.4668%
-1,525.335%
-520.1465%
-579.6383%
-479.359%
-535.5495%
-1,529.5905%
-727.1899%
-1,256.2203%
-1,477.5885%
-1,012.7389%
-3,054.0609%
-2,728.5714%
-1,872.9469%
-1,258.5533%
-137.9404%
83.071%
-327.1605%
-336.1675%
-435.232%
-501.041%
-474.1284%
-459.7749%
-303.3898%
-434.9701%
-405.897%
-10,499.3548%
-14,410.3774%
-978.2158%
-895.5634%
-510.8675%
-537.4124%
-441.2644%
-401.2442%
-515.4987%
-401.3475%
-300.2069%
-87.7621%
-1,532.6399%
100%
-185.278%
-182.139%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.